AMLYPAVE
LIVE

Serial Number

99216119

Owner

Alexion Pharmaceuticals, Inc.

Attorney

Cara M. Kearney

Filing Date

Jun 3, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AMLYPAVE Trademark

Serial Number: 99216119

AMLYPAVE is a trademark filed by Alexion Pharmaceuticals, Inc. on June 3, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

June 3, 2025

Registration Date

Not Registered

Published for Opposition

November 25, 2025

Goods & Services

Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jun 8, 2026 EX1G
SOU EXTENSION 1 FILED
Jun 8, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2025 CNSA
ASSIGNED TO EXAMINER
Oct 23, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 3, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2025 NWOS
NEW APPLICATION ENTERED
Jun 3, 2025 NWAP